Estrogen
10
2
4
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 10 trials
100.0%
+13.5% vs benchmark
30%
3 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (10)
Disentangling the Effects of Daily Stress, Sleep, and Sex Hormones on Accelerated Vascular Aging in Midlife Women
Impact of Estradiol on Endothelial Function in Peri-Menopausal Women
Estrogen and Microvascular Function
Assessment of the Improvement in Cognitive Levels of Postmenopausal Depression Patients by Estrogen
Comparative Study of Tranexamic Acid, Estrogen for Treatment AUB in DMPA Users
The Relationship of Phthalate Exposure During Pregnancy and Preeclampsia
Estrogen Supplementation Mode in HRT-FET Cycle: a RCT
Dissecting the Role of Estradiol in Mediating Gender-specific Anxiolytic and Prosocial Effects of Oxytocin
Patient Adherence to Premarin Versus Vagifem Therapy After Female Pelvic Reconstructive Surgery
Zoladex Plus Tamoxifen in Breast Cancer